In the current trading session, Silexion Therapeutics Corp’s (SLXN) stock is trading at the price of $1.27, a fall of -3.21% over last night’s close. So, the stock is trading at a price that is -98.96% less than its 52-week high of $122.02 and 120.52% better than its 52-week low of $0.57. Based on the past 30-day period, the stock price is -29.64% below the high and +70.21% above the low.
How does Silexion Therapeutics Corp (SLXN) stock rate among analysts? Buy, sell, or hold?
The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 1 brokerage firms that recommend the stock as a Strong Buy. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 5.00 in simple terms.
Silexion Therapeutics Corp (NASDAQ: SLXN) Ownership Details
I will give a breakdown of the key shareholders in Silexion Therapeutics Corp (SLXN). Recent figures show that the company’s insiders hold 13.25% of shares. A total of 5 institutional investors hold shares in the company, making 14.80% of its stock and 17.06% of its float.
Dec 31, 2024, it was reported that the Company’s largest institutional holder is Wildcat Capital Management, LLC holding total of 113.43 shares that make 1.35% of the company’s total number of shares and are currently priced at 0.14 million.
The securities firm UBS Group AG holds 14.85 shares of SLXN, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.18%, and the holding percentage of shares is valued at 18864.0.
An overview of Silexion Therapeutics Corp’s technicals
In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests Silexion Therapeutics Corp (SLXN) traded 9,873,272 shares per day, with a moving average of $1.1532 and price change of +0.1724. With the moving average of $1.3516 and a price change of -0.7576, about 17,071,266 shares changed hands on average over the past 50 days. Finally, SLXN’s 100-day average volume is 9,019,990 shares, alongside a moving average of $1.9954 and a price change of -2.0686.
